The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

Nearly 40 million individuals globally are currently living with HIV, a virus that has resulted in the loss of over 42 ...

Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks a milestone in HIV prevention, but experts warn over its expense. Sophie Cousins reports.

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Tens of millions of people worldwide live with HIV. Lenacapavir can prevent the virus for months with one injection — a ...